Sign in to view content

Safety and Efficacy of Risuteganib in Intermediate Nonexudative AMD: First Time Results From a Phase 2 Study

Peter K. Kaiser, MD FASRS

Video
Published 2019

Peter K. Kaiser, MD

AMD Non-neovascular Symposium

Related

Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2018
Protocol T Extension Results
John A. Wells, MD, FACS
Updates from the Field
2019
Associations Between Perifoveal Drusen Burden and Genetic Risk in Eyes With Early or Intermediate Age-Related Macular Degeneration
Johanna M. Seddon, MD, ScM, FARVO, FASRS
Annual Meeting Talks
2019

Category: AMD-Non-Neovascular

See more